-
1
-
-
84922480270
-
Association of interleukin-6 with the progression of carotid atherosclerosis: a 9-year follow-up study
-
COI: 1:CAS:528:DC%2BC2cXhs1Kms7zJ
-
Okazaki S, Sakaguchi M, Miwa K, et al. Association of interleukin-6 with the progression of carotid atherosclerosis: a 9-year follow-up study. Stroke; J Cereb Circ. 2014;45:2924–9.
-
(2014)
Stroke; J Cereb Circ
, vol.45
, pp. 2924-2929
-
-
Okazaki, S.1
Sakaguchi, M.2
Miwa, K.3
-
2
-
-
84861307167
-
Pathophysiology of atherosclerosis: the role of inflammation
-
COI: 1:CAS:528:DC%2BC38XovFWqsw%3D%3D, PID: 22204371
-
Tousoulis D, Kampoli AM, Papageorgiou N, et al. Pathophysiology of atherosclerosis: the role of inflammation. Curr Pharm Des. 2011;17:4089–110.
-
(2011)
Curr Pharm Des
, vol.17
, pp. 4089-4110
-
-
Tousoulis, D.1
Kampoli, A.M.2
Papageorgiou, N.3
-
3
-
-
0033021172
-
Pathophysiology and clinical significance of atherosclerotic plaque rupture
-
COI: 1:CAS:528:DyaK1MXht12rurc%3D, PID: 10341832
-
Gutstein DE, Fuster V. Pathophysiology and clinical significance of atherosclerotic plaque rupture. Cardiovasc Res. 1999;41:323–33.
-
(1999)
Cardiovasc Res
, vol.41
, pp. 323-333
-
-
Gutstein, D.E.1
Fuster, V.2
-
4
-
-
79958231551
-
The endothelium and its role in regulating vascular tone
-
PID: 21339899
-
Sandoo A, van Zanten JJ, Metsios GS, Carroll D, Kitas GD. The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J. 2010;4:302–12.
-
(2010)
Open Cardiovasc Med J
, vol.4
, pp. 302-312
-
-
Sandoo, A.1
van Zanten, J.J.2
Metsios, G.S.3
Carroll, D.4
Kitas, G.D.5
-
5
-
-
4444221859
-
Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins
-
COI: 1:CAS:528:DC%2BD2cXntVCru7Y%3D, PID: 15256399
-
Guzik TJ, Sadowski J, Kapelak B, et al. Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins. Arterioscler Thromb Vasc Biol. 2004;24:1614–20.
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 1614-1620
-
-
Guzik, T.J.1
Sadowski, J.2
Kapelak, B.3
-
6
-
-
33947716172
-
Endothelial function and dysfunction: testing and clinical relevance
-
PID: 17353456
-
Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115:1285–95.
-
(2007)
Circulation
, vol.115
, pp. 1285-1295
-
-
Deanfield, J.E.1
Halcox, J.P.2
Rabelink, T.J.3
-
7
-
-
77956813371
-
Comparative pharmacology of chemically distinct NADPH oxidase inhibitors
-
COI: 1:CAS:528:DC%2BC3cXht1Kju7zN, PID: 20860666
-
Wind S, Beuerlein K, Eucker T, et al. Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br J Pharmacol. 2010;161:885–98.
-
(2010)
Br J Pharmacol
, vol.161
, pp. 885-898
-
-
Wind, S.1
Beuerlein, K.2
Eucker, T.3
-
8
-
-
0030928673
-
Both intracellular and extracellular vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells
-
COI: 1:CAS:528:DyaK2sXmtFKisbY%3D, PID: 9301639
-
Martin A, Frei B. Both intracellular and extracellular vitamin C inhibit atherogenic modification of LDL by human vascular endothelial cells. Arterioscler Thromb Vasc Biol. 1997;17:1583–90.
-
(1997)
Arterioscler Thromb Vasc Biol
, vol.17
, pp. 1583-1590
-
-
Martin, A.1
Frei, B.2
-
9
-
-
84883804973
-
Effect of soy isoflavone supplementation on vascular endothelial function and oxidative stress in postmenopausal women: a community randomized controlled trial
-
COI: 1:CAS:528:DC%2BC3sXhsFGgsLrN, PID: 23945405
-
Pusparini, Dharma R, Suyatna FD, Mansyur M, Hidajat A. Effect of soy isoflavone supplementation on vascular endothelial function and oxidative stress in postmenopausal women: a community randomized controlled trial. Asia Pac J Clin Nutr. 2013;22:357–64.
-
(2013)
Asia Pac J Clin Nutr
, vol.22
, pp. 357-364
-
-
Pusparini1
Dharma, R.2
Suyatna, F.D.3
Mansyur, M.4
Hidajat, A.5
-
10
-
-
84890532909
-
Favorable effects of concord grape juice on endothelial function and arterial stiffness in healthy smokers
-
COI: 1:CAS:528:DC%2BC3sXhvV2lsL3P, PID: 24061071
-
Siasos G, Tousoulis D, Kokkou E, et al. Favorable effects of concord grape juice on endothelial function and arterial stiffness in healthy smokers. Am J Hypertens. 2014;27:38–45.
-
(2014)
Am J Hypertens
, vol.27
, pp. 38-45
-
-
Siasos, G.1
Tousoulis, D.2
Kokkou, E.3
-
11
-
-
0030729963
-
Evidence that initiated keratinocytes clonally expand into multiple existing hair follicles during papilloma histogenesis in SENCAR mouse skin
-
COI: 1:CAS:528:DyaK2sXms1Smtbo%3D, PID: 9328446
-
Binder RL, Gallagher PM, Johnson GR, et al. Evidence that initiated keratinocytes clonally expand into multiple existing hair follicles during papilloma histogenesis in SENCAR mouse skin. Mol Carcinog. 1997;20:151–8.
-
(1997)
Mol Carcinog
, vol.20
, pp. 151-158
-
-
Binder, R.L.1
Gallagher, P.M.2
Johnson, G.R.3
-
12
-
-
3242761489
-
Physiology of the endothelium
-
COI: 1:CAS:528:DC%2BD2cXkvVSruro%3D, PID: 15121728
-
Galley HF, Webster NR. Physiology of the endothelium. Br J Anaesth. 2004;93:105–13.
-
(2004)
Br J Anaesth
, vol.93
, pp. 105-113
-
-
Galley, H.F.1
Webster, N.R.2
-
13
-
-
0025321355
-
Biosynthesis and metabolism of endothelium-derived nitric oxide
-
COI: 1:CAS:528:DyaK3MXitFakug%3D%3D, PID: 2188578
-
Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol. 1990;30:535–60.
-
(1990)
Annu Rev Pharmacol Toxicol
, vol.30
, pp. 535-560
-
-
Ignarro, L.J.1
-
14
-
-
33645755859
-
Endothelial dysfunction: a comprehensive appraisal
-
PID: 16504104
-
Esper RJ, Nordaby RA, Vilarino JO, Paragano A, Cacharron JL, Machado RA. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol. 2006;5:4.
-
(2006)
Cardiovasc Diabetol
, vol.5
, pp. 4
-
-
Esper, R.J.1
Nordaby, R.A.2
Vilarino, J.O.3
Paragano, A.4
Cacharron, J.L.5
Machado, R.A.6
-
15
-
-
0028298226
-
Endothelial nitric oxide and cardiovascular disease
-
COI: 1:CAS:528:DyaK2cXksl2lsrY%3D, PID: 8151263
-
Wennmalm A. Endothelial nitric oxide and cardiovascular disease. J Intern Med. 1994;235:317–27.
-
(1994)
J Intern Med
, vol.235
, pp. 317-327
-
-
Wennmalm, A.1
-
16
-
-
84925524089
-
Laminar shear stress regulates mitochondrial dynamics, bioenergetics responses and PRX3 activation in endothelial cells
-
Breton-Romero R, Acin-Perez R, Rodriguez-Pascual F, et al. Laminar shear stress regulates mitochondrial dynamics, bioenergetics responses and PRX3 activation in endothelial cells. Biochim Biophys Acta. 1843;2014:2403–13.
-
(1843)
Biochim Biophys Acta
, vol.2014
, pp. 2403-2413
-
-
Breton-Romero, R.1
Acin-Perez, R.2
Rodriguez-Pascual, F.3
-
17
-
-
79961031512
-
Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling
-
COI: 1:CAS:528:DC%2BC3MXptVChsLw%3D, PID: 21730307
-
Antoniades C, Bakogiannis C, Leeson P, et al. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Circulation. 2011;124:335–45.
-
(2011)
Circulation
, vol.124
, pp. 335-345
-
-
Antoniades, C.1
Bakogiannis, C.2
Leeson, P.3
-
18
-
-
17644412023
-
Inflammation, atherosclerosis, and coronary artery disease
-
COI: 1:CAS:528:DC%2BD2MXjsFCltrc%3D, PID: 15843671
-
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–95.
-
(2005)
N Engl J Med
, vol.352
, pp. 1685-1695
-
-
Hansson, G.K.1
-
19
-
-
84907261051
-
Relationship between markers of endothelial dysfunction and inflammation and subclinical atherosclerosis in HIV-infected male patients below 55 years of age
-
PID: 25242160
-
Pirs M, Jug B, Erzen B, et al. Relationship between markers of endothelial dysfunction and inflammation and subclinical atherosclerosis in HIV-infected male patients below 55 years of age. Acta dermatovenerologica Alpina, Pannonica, et Adriatica. 2014;23:49–52.
-
(2014)
Acta dermatovenerologica Alpina, Pannonica, et Adriatica
, vol.23
, pp. 49-52
-
-
Pirs, M.1
Jug, B.2
Erzen, B.3
-
20
-
-
84911913918
-
Coronary Endothelial Dysfunction Is Associated With Inflammation and Vasa Vasorum Proliferation in Patients with Early Atherosclerosis
-
Choi BJ, Matsuo Y, Aoki T et al. Coronary Endothelial Dysfunction Is Associated With Inflammation and Vasa Vasorum Proliferation in Patients with Early Atherosclerosis. Arterioscler Thromb Vasc Biol 2014.
-
(2014)
Arterioscler Thromb Vasc Biol
-
-
Choi, B.J.1
Matsuo, Y.2
Aoki, T.3
-
21
-
-
67649552969
-
Risk prediction in cardiovascular disease: the prognostic significance of endothelial dysfunction
-
PID: 19521569
-
Martin BJ, Anderson TJ. Risk prediction in cardiovascular disease: the prognostic significance of endothelial dysfunction. Can J Cardiol. 2009;25(Suppl A):15A–20A.
-
(2009)
Can J Cardiol
, vol.25
, pp. 15A-20A
-
-
Martin, B.J.1
Anderson, T.J.2
-
22
-
-
0037031266
-
Prognostic value of coronary vascular endothelial dysfunction
-
PID: 12163423
-
Halcox JP, Schenke WH, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106:653–8.
-
(2002)
Circulation
, vol.106
, pp. 653-658
-
-
Halcox, J.P.1
Schenke, W.H.2
Zalos, G.3
-
23
-
-
3142750573
-
Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia
-
PID: 12724051
-
John S, Schmieder RE. Potential mechanisms of impaired endothelial function in arterial hypertension and hypercholesterolemia. Curr Hypertens Rep. 2003;5:199–207.
-
(2003)
Curr Hypertens Rep
, vol.5
, pp. 199-207
-
-
John, S.1
Schmieder, R.E.2
-
24
-
-
0031966827
-
Does lipoprotein (a) impair endothelial function?
-
COI: 1:CAS:528:DyaK1cXhtVCqt7Y%3D, PID: 9462580
-
Schlaich MP, John S, Langenfeld MR, Lackner KJ, Schmitz G, Schmieder RE. Does lipoprotein (a) impair endothelial function? J Am Coll Cardiol. 1998;31:359–65.
-
(1998)
J Am Coll Cardiol
, vol.31
, pp. 359-365
-
-
Schlaich, M.P.1
John, S.2
Langenfeld, M.R.3
Lackner, K.J.4
Schmitz, G.5
Schmieder, R.E.6
-
25
-
-
19944430327
-
Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the working group on endothelin and endothelial factors of the European society of hypertension
-
COI: 1:CAS:528:DC%2BD2MXitVCjsQ%3D%3D, PID: 15643116
-
Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the working group on endothelin and endothelial factors of the European society of hypertension. J Hypertens. 2005;23:7–17.
-
(2005)
J Hypertens
, vol.23
, pp. 7-17
-
-
Deanfield, J.1
Donald, A.2
Ferri, C.3
-
26
-
-
0242349754
-
Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index
-
PID: 14530195
-
Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation. 2003;108:2093–8.
-
(2003)
Circulation
, vol.108
, pp. 2093-2098
-
-
Brevetti, G.1
Silvestro, A.2
Schiano, V.3
Chiariello, M.4
-
27
-
-
0042234294
-
The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease
-
COI: 1:CAS:528:DC%2BD3sXotVeitb8%3D, PID: 13678927
-
Chan SY, Mancini GB, Kuramoto L, Schulzer M, Frohlich J, Ignaszewski A. The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. J Am Coll Cardiol. 2003;42:1037–43.
-
(2003)
J Am Coll Cardiol
, vol.42
, pp. 1037-1043
-
-
Chan, S.Y.1
Mancini, G.B.2
Kuramoto, L.3
Schulzer, M.4
Frohlich, J.5
Ignaszewski, A.6
-
28
-
-
58849097205
-
Prognostic value of flow-mediated dilatation following myocardial infarction
-
PID: 18180054
-
Guazzi M, Reina G, Gripari P, Tumminello G, Vicenzi M, Arena R. Prognostic value of flow-mediated dilatation following myocardial infarction. Int J Cardiol. 2009;132:45–50.
-
(2009)
Int J Cardiol
, vol.132
, pp. 45-50
-
-
Guazzi, M.1
Reina, G.2
Gripari, P.3
Tumminello, G.4
Vicenzi, M.5
Arena, R.6
-
29
-
-
0033552883
-
Atherosclerosis–an inflammatory disease
-
COI: 1:STN:280:DyaK1M%2FptFSqtQ%3D%3D, PID: 9887164
-
Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med. 1999;340:115–26.
-
(1999)
N Engl J Med
, vol.340
, pp. 115-126
-
-
Ross, R.1
-
30
-
-
0029955130
-
Endothelial dysfunction in coronary heart disease
-
COI: 1:STN:280:DyaK2s%2FjsVarug%3D%3D, PID: 8879944
-
McGorisk GM, Treasure CB. Endothelial dysfunction in coronary heart disease. Curr Opin Cardiol. 1996;11:341–50.
-
(1996)
Curr Opin Cardiol
, vol.11
, pp. 341-350
-
-
McGorisk, G.M.1
Treasure, C.B.2
-
31
-
-
0035909222
-
Why vascular biology matters
-
COI: 1:CAS:528:DC%2BD3MXnvFCqsrs%3D, PID: 11694212
-
Pepine CJ. Why vascular biology matters. Am J Cardiol. 2001;88:5K–9K.
-
(2001)
Am J Cardiol
, vol.88
, pp. 5K-9K
-
-
Pepine, C.J.1
-
32
-
-
10644222784
-
Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis
-
COI: 1:CAS:528:DC%2BD2cXhtVaisrvO, PID: 15472124
-
Khalil MF, Wagner WD, Goldberg IJ. Molecular interactions leading to lipoprotein retention and the initiation of atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24:2211–8.
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 2211-2218
-
-
Khalil, M.F.1
Wagner, W.D.2
Goldberg, I.J.3
-
33
-
-
34547227303
-
Assessing inflammatory status in cardiovascular disease
-
COI: 1:CAS:528:DC%2BD2sXpsFartbo%3D, PID: 17639118
-
Tousoulis D, Antoniades C, Stefanadis C. Assessing inflammatory status in cardiovascular disease. Heart. 2007;93:1001–7.
-
(2007)
Heart
, vol.93
, pp. 1001-1007
-
-
Tousoulis, D.1
Antoniades, C.2
Stefanadis, C.3
-
34
-
-
84890793830
-
Mycophenolic acid attenuates the tumour necrosis factor-alpha-mediated proinflammatory response in endothelial cells by blocking the MAPK/NF-kappaB and ROS pathways
-
COI: 1:CAS:528:DC%2BC3sXhvF2kurnF, PID: 24134657
-
Olejarz W, Bryk D, Zapolska-Downar D, Malecki M, Stachurska A, Sitkiewicz D. Mycophenolic acid attenuates the tumour necrosis factor-alpha-mediated proinflammatory response in endothelial cells by blocking the MAPK/NF-kappaB and ROS pathways. Eur J Clin Invest. 2014;44:54–64.
-
(2014)
Eur J Clin Invest
, vol.44
, pp. 54-64
-
-
Olejarz, W.1
Bryk, D.2
Zapolska-Downar, D.3
Malecki, M.4
Stachurska, A.5
Sitkiewicz, D.6
-
35
-
-
61949233502
-
Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential
-
COI: 1:CAS:528:DC%2BD1MXhsV2jsLk%3D, PID: 19213965
-
Martinet W, De Meyer GR. Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ Res. 2009;104:304–17.
-
(2009)
Circ Res
, vol.104
, pp. 304-317
-
-
Martinet, W.1
De Meyer, G.R.2
-
36
-
-
0033815506
-
Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death
-
COI: 1:CAS:528:DC%2BD3cXnsVKju7o%3D, PID: 11021830
-
Kolodgie FD, Narula J, Burke AP, et al. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol. 2000;157:1259–68.
-
(2000)
Am J Pathol
, vol.157
, pp. 1259-1268
-
-
Kolodgie, F.D.1
Narula, J.2
Burke, A.P.3
-
37
-
-
58149166857
-
Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: evidence of an oxidant-sensitive pathway
-
PID: 19079593
-
Desideri G, Grassi D, Croce G, et al. Different effects of angiotensin converting enzyme inhibitors on endothelin-1 and nitric oxide balance in human vascular endothelial cells: evidence of an oxidant-sensitive pathway. Mediators Inflamm. 2008;2008:305087.
-
(2008)
Mediators Inflamm
, vol.2008
, pp. 305087
-
-
Desideri, G.1
Grassi, D.2
Croce, G.3
-
38
-
-
78649316862
-
The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice
-
PID: 20857126
-
Poss J, Werner C, Lorenz D, Gensch C, Bohm M, Laufs U. The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice. Basic Res Cardiol. 2010;105:725–35.
-
(2010)
Basic Res Cardiol
, vol.105
, pp. 725-735
-
-
Poss, J.1
Werner, C.2
Lorenz, D.3
Gensch, C.4
Bohm, M.5
Laufs, U.6
-
39
-
-
77955981695
-
Effect of eplerenone on endothelial progenitor cells and oxidative stress in ischemic hindlimb
-
COI: 1:CAS:528:DC%2BC3cXhtVKhu7fI, PID: 20431528
-
Kobayashi N, Fukushima H, Takeshima H, et al. Effect of eplerenone on endothelial progenitor cells and oxidative stress in ischemic hindlimb. Am J Hypertens. 2010;23:1007–13.
-
(2010)
Am J Hypertens
, vol.23
, pp. 1007-1013
-
-
Kobayashi, N.1
Fukushima, H.2
Takeshima, H.3
-
40
-
-
84865589272
-
Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts
-
COI: 1:CAS:528:DC%2BC38XhtFOqsr3E, PID: 22549451
-
Noda K, Kobara M, Hamada J, et al. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts. J Cardiovasc Pharmacol. 2012;60:140–9.
-
(2012)
J Cardiovasc Pharmacol
, vol.60
, pp. 140-149
-
-
Noda, K.1
Kobara, M.2
Hamada, J.3
-
41
-
-
33750600184
-
Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats
-
COI: 1:CAS:528:DC%2BD28XpsFOrs7s%3D, PID: 16940222
-
Oelze M, Daiber A, Brandes RP, et al. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension. 2006;48:677–84.
-
(2006)
Hypertension
, vol.48
, pp. 677-684
-
-
Oelze, M.1
Daiber, A.2
Brandes, R.P.3
-
42
-
-
84861312463
-
Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function
-
COI: 1:CAS:528:DC%2BC38XotlWmt7s%3D, PID: 22220498
-
Hernanz R, Martin A, Perez-Giron JV, et al. Pioglitazone treatment increases COX-2-derived prostacyclin production and reduces oxidative stress in hypertensive rats: role in vascular function. Br J Pharmacol. 2012;166:1303–19.
-
(2012)
Br J Pharmacol
, vol.166
, pp. 1303-1319
-
-
Hernanz, R.1
Martin, A.2
Perez-Giron, J.V.3
-
43
-
-
84859831151
-
A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO-related pathways
-
COI: 1:CAS:528:DC%2BC38XlvVSnu7o%3D, PID: 21684136
-
Tsai KL, Huang YH, Kao CL, et al. A novel mechanism of coenzyme Q10 protects against human endothelial cells from oxidative stress-induced injury by modulating NO-related pathways. J Nutr Biochem. 2012;23:458–68.
-
(2012)
J Nutr Biochem
, vol.23
, pp. 458-468
-
-
Tsai, K.L.1
Huang, Y.H.2
Kao, C.L.3
-
44
-
-
84884178077
-
TLR4-mediated anti-atherosclerosis mechanisms of angiotensin-converting enzyme inhibitor–fosinopril
-
COI: 1:CAS:528:DC%2BC3sXhsl2ms73I, PID: 24044965
-
Yang S, Li R, Tang L, et al. TLR4-mediated anti-atherosclerosis mechanisms of angiotensin-converting enzyme inhibitor–fosinopril. Cell Immunol. 2013;285:38–41.
-
(2013)
Cell Immunol
, vol.285
, pp. 38-41
-
-
Yang, S.1
Li, R.2
Tang, L.3
-
45
-
-
84905843088
-
Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation
-
COI: 1:CAS:528:DC%2BC2cXht1Grt77F, PID: 25016365
-
Clancy P, Koblar SA, Golledge J. Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation. Atherosclerosis. 2014;236:108–15.
-
(2014)
Atherosclerosis
, vol.236
, pp. 108-115
-
-
Clancy, P.1
Koblar, S.A.2
Golledge, J.3
-
46
-
-
1842636400
-
Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in type 1 diabetes
-
COI: 1:CAS:528:DC%2BD2cXjslGjsb8%3D, PID: 15136972
-
Komers R, Simkova R, Kazdova L, Ruzickova J, Pelikanova T. Effects of ACE inhibition and AT1-receptor blockade on haemodynamic responses to L-arginine in type 1 diabetes. J Renin-Angiotensin-Aldosterone Syst: JRAAS. 2004;5:33–8.
-
(2004)
J Renin-Angiotensin-Aldosterone Syst: JRAAS
, vol.5
, pp. 33-38
-
-
Komers, R.1
Simkova, R.2
Kazdova, L.3
Ruzickova, J.4
Pelikanova, T.5
-
47
-
-
34249869003
-
Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes
-
COI: 1:CAS:528:DC%2BD2sXntlWksLs%3D, PID: 17337492
-
Schmieder RE, Delles C, Mimran A, Fauvel JP, Ruilope LM. Impact of telmisartan versus ramipril on renal endothelial function in patients with hypertension and type 2 diabetes. Diabetes Care. 2007;30:1351–6.
-
(2007)
Diabetes Care
, vol.30
, pp. 1351-1356
-
-
Schmieder, R.E.1
Delles, C.2
Mimran, A.3
Fauvel, J.P.4
Ruilope, L.M.5
-
48
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators
-
COI: 1:STN:280:DC%2BD3c%2Fpt1emug%3D%3D, PID: 10639539
-
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med. 2000;342:145–53.
-
(2000)
N Engl J Med
, vol.342
, pp. 145-153
-
-
Yusuf, S.1
Sleight, P.2
Pogue, J.3
Bosch, J.4
Davies, R.5
Dagenais, G.6
-
49
-
-
0035328174
-
The QUinapril ischemic event trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function
-
COI: 1:STN:280:DC%2BD3MzntFWqsg%3D%3D, PID: 11348602
-
Pitt B, O'Neill B, Feldman R, et al. The QUinapril ischemic event trial (QUIET): evaluation of chronic ACE inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function. Am J Cardiol. 2001;87:1058–63.
-
(2001)
Am J Cardiol
, vol.87
, pp. 1058-1063
-
-
Pitt, B.1
O'Neill, B.2
Feldman, R.3
-
50
-
-
0031436138
-
Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND investigators. Trial on reversing endothelial dysfunction
-
COI: 1:STN:280:DyaK1c%2FnslChtw%3D%3D, PID: 9416943
-
Schlaifer JD, Wargovich TJ, O'Neill B, et al. Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. TREND investigators. Trial on reversing endothelial dysfunction. Am J Cardiol. 1997;80:1594–7.
-
(1997)
Am J Cardiol
, vol.80
, pp. 1594-1597
-
-
Schlaifer, J.D.1
Wargovich, T.J.2
O'Neill, B.3
-
51
-
-
0030915462
-
Improved endothelial function with angiotensin-converting enzyme inhibitors
-
COI: 1:CAS:528:DyaK2sXit1GlsLg%3D, PID: 9127619
-
Pepine CJ. Improved endothelial function with angiotensin-converting enzyme inhibitors. Am J Cardiol. 1997;79:29–32.
-
(1997)
Am J Cardiol
, vol.79
, pp. 29-32
-
-
Pepine, C.J.1
-
52
-
-
77349125414
-
Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial
-
COI: 1:CAS:528:DC%2BC3cXktlyrsbo%3D, PID: 20202514
-
Hirohata A, Yamamoto K, Miyoshi T, et al. Impact of olmesartan on progression of coronary atherosclerosis a serial volumetric intravascular ultrasound analysis from the OLIVUS (impact of OLmesarten on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) trial. J Am Coll Cardiol. 2010;55:976–82.
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 976-982
-
-
Hirohata, A.1
Yamamoto, K.2
Miyoshi, T.3
-
53
-
-
84155172795
-
Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) extension trial
-
COI: 1:CAS:528:DC%2BC3MXhs12htL%2FI, PID: 22119063
-
Hirohata A, Yamamoto K, Miyoshi T, et al. Four-year clinical outcomes of the OLIVUS-Ex (impact of Olmesartan on progression of coronary atherosclerosis: evaluation by intravascular ultrasound) extension trial. Atherosclerosis. 2012;220:134–8.
-
(2012)
Atherosclerosis
, vol.220
, pp. 134-138
-
-
Hirohata, A.1
Yamamoto, K.2
Miyoshi, T.3
-
54
-
-
84857135135
-
Hypertension and endothelial dysfunction: therapeutic approach
-
COI: 1:CAS:528:DC%2BC38XhtlSltLo%3D, PID: 22112351
-
Ghiadoni L, Taddei S, Virdis A. Hypertension and endothelial dysfunction: therapeutic approach. Curr Vasc Pharmacol. 2012;10:42–60.
-
(2012)
Curr Vasc Pharmacol
, vol.10
, pp. 42-60
-
-
Ghiadoni, L.1
Taddei, S.2
Virdis, A.3
-
55
-
-
84857751950
-
Endothelial dysfunction and atherosclerosis: focus on novel therapeutic approaches
-
COI: 1:CAS:528:DC%2BC38XltVOmsr8%3D, PID: 22280336
-
Briasoulis A, Tousoulis D, Androulakis ES, Papageorgiou N, Latsios G, Stefanadis C. Endothelial dysfunction and atherosclerosis: focus on novel therapeutic approaches. Recent Pat Cardiovasc Drug Discov. 2012;7:21–32.
-
(2012)
Recent Pat Cardiovasc Drug Discov
, vol.7
, pp. 21-32
-
-
Briasoulis, A.1
Tousoulis, D.2
Androulakis, E.S.3
Papageorgiou, N.4
Latsios, G.5
Stefanadis, C.6
-
56
-
-
59849109480
-
Bradykinin protects against oxidative stress-induced endothelial cell senescence
-
COI: 1:CAS:528:DC%2BD1MXlvFWjtg%3D%3D, PID: 19075096
-
Oeseburg H, Iusuf D, van der Harst P, van Gilst WH, Henning RH, Roks AJ. Bradykinin protects against oxidative stress-induced endothelial cell senescence. Hypertension. 2009;53:417–22.
-
(2009)
Hypertension
, vol.53
, pp. 417-422
-
-
Oeseburg, H.1
Iusuf, D.2
van der Harst, P.3
van Gilst, W.H.4
Henning, R.H.5
Roks, A.J.6
-
57
-
-
33646825008
-
Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition
-
COI: 1:CAS:528:DC%2BD28Xltlenurc%3D, PID: 16214149
-
Kobayashi N, Honda T, Yoshida K, et al. Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition. Atherosclerosis. 2006;187:92–100.
-
(2006)
Atherosclerosis
, vol.187
, pp. 92-100
-
-
Kobayashi, N.1
Honda, T.2
Yoshida, K.3
-
58
-
-
62149083789
-
Secondary prevention of coronary disease with ACE inhibition–does blood pressure reduction with perindopril explain the benefits in EUROPA?
-
Remme WJ, Deckers JW, Fox KM, et al. Secondary prevention of coronary disease with ACE inhibition–does blood pressure reduction with perindopril explain the benefits in EUROPA? Cardiovasc Drugs Ther Sponsored Int Soc Cardiovasc Pharmacother. 2009;23:161–70.
-
(2009)
Cardiovasc Drugs Ther Sponsored Int Soc Cardiovasc Pharmacother
, vol.23
, pp. 161-170
-
-
Remme, W.J.1
Deckers, J.W.2
Fox, K.M.3
-
59
-
-
62149100670
-
Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate ‘EUROPA’ story
-
COI: 1:CAS:528:DC%2BD1MXls1ymu7g%3D, PID: 19275271
-
Ferrari R, Fox K. Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate ‘EUROPA’ story. Drugs. 2009;69:265–77.
-
(2009)
Drugs
, vol.69
, pp. 265-277
-
-
Ferrari, R.1
Fox, K.2
-
60
-
-
0031698238
-
EUROPA substudies, confirmation of pathophysiological concepts. European trial on reduction of cardiac events with perindopril in stable coronary artery disease
-
PID: 9796842
-
Simoons ML, Vos J, de Feyter PJ, et al. EUROPA substudies, confirmation of pathophysiological concepts. European trial on reduction of cardiac events with perindopril in stable coronary artery disease. Eur Heart J. 1998;19:J56–60.
-
(1998)
Eur Heart J
, vol.19
, pp. J56-J60
-
-
Simoons, M.L.1
Vos, J.2
de Feyter, P.J.3
-
61
-
-
34548557745
-
ACE inhibition and endothelial function: main findings of PERFECT, a sub-study of the EUROPA trial
-
COI: 1:CAS:528:DC%2BD2sXhtVagtbjE
-
Bots ML, Remme WJ, Luscher TF, et al. ACE inhibition and endothelial function: main findings of PERFECT, a sub-study of the EUROPA trial. Cardiovasc Drugs Ther Sponsored Int Soc Cardiovasc Pharmacother. 2007;21:269–79.
-
(2007)
Cardiovasc Drugs Ther Sponsored Int Soc Cardiovasc Pharmacother
, vol.21
, pp. 269-279
-
-
Bots, M.L.1
Remme, W.J.2
Luscher, T.F.3
-
62
-
-
36848999385
-
Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies
-
COI: 1:CAS:528:DC%2BD2sXhtl2ks7zF
-
Ceconi C, Francolini G, Bastianon D, Gitti GL, Comini L, Ferrari R. Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies. Cardiovasc Drugs Ther Sponsored Int Soc Cardiovasc Pharmacother. 2007;21:423–9.
-
(2007)
Cardiovasc Drugs Ther Sponsored Int Soc Cardiovasc Pharmacother
, vol.21
, pp. 423-429
-
-
Ceconi, C.1
Francolini, G.2
Bastianon, D.3
Gitti, G.L.4
Comini, L.5
Ferrari, R.6
-
63
-
-
36849024567
-
Secondary prevention of coronary artery disease and the choice of the ACE inhibitor why EUROPA and not PEACE
-
Remme WJ. Secondary prevention of coronary artery disease and the choice of the ACE inhibitor why EUROPA and not PEACE. Cardiovasc Drugs Ther Sponsored Int Soc Cardiovasc Pharmacother. 2007;21:405–7.
-
(2007)
Cardiovasc Drugs Ther Sponsored Int Soc Cardiovasc Pharmacother
, vol.21
, pp. 405-407
-
-
Remme, W.J.1
-
64
-
-
4844231461
-
Olmesartan EUTo, Pravastatin in I, Atherosclerosis I. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation
-
COI: 1:CAS:528:DC%2BD2cXmvV2gt7Y%3D, PID: 15313950
-
Fliser D, Buchholz K, Haller H. Olmesartan EUTo, Pravastatin in I, Atherosclerosis I. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation. 2004;110:1103–7.
-
(2004)
Circulation
, vol.110
, pp. 1103-1107
-
-
Fliser, D.1
Buchholz, K.2
Haller, H.3
-
65
-
-
83755179668
-
Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil
-
PID: 21796255
-
Mason RP. Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil. Vasc Health Risk Manag. 2011;7:405–16.
-
(2011)
Vasc Health Risk Manag
, vol.7
, pp. 405-416
-
-
Mason, R.P.1
-
66
-
-
47249091972
-
Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The multicentre olmesartan atherosclerosis regression evaluation (MORE) study
-
PID: 19124398
-
Stumpe KO, Agabiti-Rosei E, Zielinski T, et al. Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The multicentre olmesartan atherosclerosis regression evaluation (MORE) study. Ther Adv Cardiovasc Dis. 2007;1:97–106.
-
(2007)
Ther Adv Cardiovasc Dis
, vol.1
, pp. 97-106
-
-
Stumpe, K.O.1
Agabiti-Rosei, E.2
Zielinski, T.3
-
67
-
-
68849129003
-
Valsartan improves endothelial dysfunction in hypertension: a randomized, double-blind study
-
COI: 1:CAS:528:DC%2BD1MXhtFCkt7nO, PID: 19604249
-
Tzemos N, Lim PO, MacDonald TM. Valsartan improves endothelial dysfunction in hypertension: a randomized, double-blind study. Cardiovasc Ther. 2009;27:151–8.
-
(2009)
Cardiovasc Ther
, vol.27
, pp. 151-158
-
-
Tzemos, N.1
Lim, P.O.2
MacDonald, T.M.3
-
68
-
-
0025913812
-
The SOLVD Investigators
-
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991;325:293–302.
-
(1991)
N Engl J Med
, vol.325
, pp. 293-302
-
-
-
69
-
-
34548420712
-
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomized controlled trial
-
COI: 1:CAS:528:DC%2BD2sXhtVWjs7zO, PID: 17765963
-
Patel A, Group AC, MacMahon S, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomized controlled trial. Lancet. 2007;370:829–40.
-
(2007)
Lancet
, vol.370
, pp. 829-840
-
-
Patel, A.1
Group, A.C.2
MacMahon, S.3
-
70
-
-
0344373794
-
The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)
-
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group
-
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The antihypertensive and lipid-lowering treatment to prevent heart attack trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). JAMA. 2002;288:2981–97.
-
(2002)
JAMA
, vol.288
, pp. 2981-2997
-
-
-
71
-
-
84886260869
-
2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology
-
Task Force M, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology. Eur Heart J. 2013;34:2949–3003.
-
(2013)
Eur Heart J
, vol.34
, pp. 2949-3003
-
-
Task Force, M.1
Montalescot, G.2
Sechtem, U.3
-
72
-
-
70349251477
-
Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice
-
COI: 1:CAS:528:DC%2BD1MXpsleksbo%3D, PID: 19597038
-
Yamamoto E, Kataoka K, Dong YF, et al. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice. Hypertension. 2009;54:633–8.
-
(2009)
Hypertension
, vol.54
, pp. 633-638
-
-
Yamamoto, E.1
Kataoka, K.2
Dong, Y.F.3
-
73
-
-
84858997658
-
The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis
-
PID: 22232539
-
Harel Z, Gilbert C, Wald R, et al. The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis. BMJ. 2012;344:e42.
-
(2012)
BMJ
, vol.344
, pp. e42
-
-
Harel, Z.1
Gilbert, C.2
Wald, R.3
-
74
-
-
68349104172
-
Nitric oxide mechanisms of nebivolol
-
PID: 19443516
-
Maffei A, Lembo G. Nitric oxide mechanisms of nebivolol. Ther Adv Cardiovasc Dis. 2009;3:317–27.
-
(2009)
Ther Adv Cardiovasc Dis
, vol.3
, pp. 317-327
-
-
Maffei, A.1
Lembo, G.2
-
75
-
-
54249107160
-
Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients
-
COI: 1:CAS:528:DC%2BD1cXht1OisLjE, PID: 18772860
-
Pasini AF, Garbin U, Stranieri C, et al. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients. Am J Hypertens. 2008;21:1251–7.
-
(2008)
Am J Hypertens
, vol.21
, pp. 1251-1257
-
-
Pasini, A.F.1
Garbin, U.2
Stranieri, C.3
-
76
-
-
70849120726
-
Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function
-
COI: 1:CAS:528:DC%2BC3cXkvF2hsw%3D%3D
-
Merchant N, Searles CD, Pandian A, et al. Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function. J Clin Hypertens (Greenwich). 2009;11:720–5.
-
(2009)
J Clin Hypertens (Greenwich)
, vol.11
, pp. 720-725
-
-
Merchant, N.1
Searles, C.D.2
Pandian, A.3
-
77
-
-
34047229326
-
Effect of DL-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells
-
COI: 1:CAS:528:DC%2BD2sXjvFGnsb0%3D, PID: 17280840
-
Evangelista S, Garbin U, Pasini AF, Stranieri C, Boccioletti V, Cominacini L. Effect of DL-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells. Pharmacol Res. 2007;55:303–9.
-
(2007)
Pharmacol Res
, vol.55
, pp. 303-309
-
-
Evangelista, S.1
Garbin, U.2
Pasini, A.F.3
Stranieri, C.4
Boccioletti, V.5
Cominacini, L.6
-
78
-
-
79953275789
-
Beneficial effects of nebivolol treatment on oxidative stress parameters in patients with slow coronary flow
-
PID: 20935430
-
Akcay A, Acar G, Kurutas E, et al. Beneficial effects of nebivolol treatment on oxidative stress parameters in patients with slow coronary flow. Turk Kardiyol Dern Ars. 2010;38:244–9.
-
(2010)
Turk Kardiyol Dern Ars
, vol.38
, pp. 244-249
-
-
Akcay, A.1
Acar, G.2
Kurutas, E.3
-
79
-
-
84900435730
-
Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound
-
PID: 24886532
-
Gao WQ, Feng QZ, Li YF, et al. Systematic study of the effects of lowering low-density lipoprotein-cholesterol on regression of coronary atherosclerotic plaques using intravascular ultrasound. BMC Cardiovasc Disord. 2014;14:60.
-
(2014)
BMC Cardiovasc Disord
, vol.14
, pp. 60
-
-
Gao, W.Q.1
Feng, Q.Z.2
Li, Y.F.3
-
80
-
-
84875053540
-
Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure
-
COI: 1:CAS:528:DC%2BC3sXivVWktbg%3D, PID: 23433403
-
Tousoulis D, Oikonomou E, Siasos G, et al. Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure. Atherosclerosis. 2013;227:367–72.
-
(2013)
Atherosclerosis
, vol.227
, pp. 367-372
-
-
Tousoulis, D.1
Oikonomou, E.2
Siasos, G.3
-
81
-
-
0037230927
-
Interrelationship of free oxygen radicals and endothelial dysfunction–modulation by statins
-
COI: 1:CAS:528:DC%2BD3sXitVCnu70%3D, PID: 12699074
-
Wassmann S, Nickenig G. Interrelationship of free oxygen radicals and endothelial dysfunction–modulation by statins. Endothelium. 2003;10:23–33.
-
(2003)
Endothelium
, vol.10
, pp. 23-33
-
-
Wassmann, S.1
Nickenig, G.2
-
82
-
-
84872794729
-
Statins as first-line therapy for acute coronary syndrome?
-
COI: 1:CAS:528:DC%2BC2cXhslOmtbfN, PID: 23592942
-
Ostadal P. Statins as first-line therapy for acute coronary syndrome? Exp Clin Cardiol. 2012;17:227–36.
-
(2012)
Exp Clin Cardiol
, vol.17
, pp. 227-236
-
-
Ostadal, P.1
-
83
-
-
0041382453
-
Fluvastatin attenuates nitrate tolerance in patients with ischemic heart disease complicating hypercholesterolemia
-
PID: 12957750
-
Inoue T, Takayanagi K, Hayashi T, Morooka S. Fluvastatin attenuates nitrate tolerance in patients with ischemic heart disease complicating hypercholesterolemia. Int J Cardiol. 2003;90:181–8.
-
(2003)
Int J Cardiol
, vol.90
, pp. 181-188
-
-
Inoue, T.1
Takayanagi, K.2
Hayashi, T.3
Morooka, S.4
-
84
-
-
34250202252
-
Analysis of antihypertensive effects of statins
-
COI: 1:CAS:528:DC%2BD2sXhtVenur%2FI, PID: 17519121
-
Milionis HJ, Liberopoulos EN, Elisaf MS, Mikhailidis DP. Analysis of antihypertensive effects of statins. Curr Hypertens Rep. 2007;9:175–83.
-
(2007)
Curr Hypertens Rep
, vol.9
, pp. 175-183
-
-
Milionis, H.J.1
Liberopoulos, E.N.2
Elisaf, M.S.3
Mikhailidis, D.P.4
-
85
-
-
84255172397
-
Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: justification for atherosclerosis regression treatment (JART) study
-
COI: 1:CAS:528:DC%2BC38XhsV2jtb4%3D, PID: 22094911
-
Nohara R, Daida H, Hata M, et al. Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: justification for atherosclerosis regression treatment (JART) study. Circ J. 2012;76:221–9.
-
(2012)
Circ J
, vol.76
, pp. 221-229
-
-
Nohara, R.1
Daida, H.2
Hata, M.3
-
86
-
-
84255172422
-
Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration: HEAVEN study
-
COI: 1:CAS:528:DC%2BC38XhsV2jtL4%3D, PID: 22076422
-
Kovarnik T, Mintz GS, Skalicka H, et al. Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration: HEAVEN study. Circ J. 2012;76:176–83.
-
(2012)
Circ J
, vol.76
, pp. 176-183
-
-
Kovarnik, T.1
Mintz, G.S.2
Skalicka, H.3
-
87
-
-
0035804846
-
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial
-
COI: 1:CAS:528:DC%2BD3MXivFGnurc%3D, PID: 11277825
-
Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA. 2001;285:1711–8.
-
(2001)
JAMA
, vol.285
, pp. 1711-1718
-
-
Schwartz, G.G.1
Olsson, A.G.2
Ezekowitz, M.D.3
-
88
-
-
77949337131
-
Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial
-
PID: 20298994
-
Kim JS, Kim J, Choi D, et al. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. JACC Cardiovasc Interv. 2010;3:332–9.
-
(2010)
JACC Cardiovasc Interv
, vol.3
, pp. 332-339
-
-
Kim, J.S.1
Kim, J.2
Choi, D.3
-
89
-
-
77953970945
-
Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)
-
PID: 20500832
-
Ostadal P, Alan D, Vejvoda J, et al. Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial). Trials. 2010;11:61.
-
(2010)
Trials
, vol.11
, pp. 61
-
-
Ostadal, P.1
Alan, D.2
Vejvoda, J.3
-
90
-
-
0032847680
-
Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction
-
COI: 1:CAS:528:DyaK1MXmtFOrtrY%3D, PID: 10479650
-
Jackson SM, Parhami F, Xi XP, et al. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol. 1999;19:2094–104.
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 2094-2104
-
-
Jackson, S.M.1
Parhami, F.2
Xi, X.P.3
-
91
-
-
0037231474
-
Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells
-
COI: 1:CAS:528:DC%2BD3sXhvVU%3D, PID: 12524224
-
Calnek DS, Mazzella L, Roser S, Roman J, Hart CM. Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells. Arterioscler Thromb Vasc Biol. 2003;23:52–7.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 52-57
-
-
Calnek, D.S.1
Mazzella, L.2
Roser, S.3
Roman, J.4
Hart, C.M.5
-
92
-
-
15444367174
-
Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production
-
COI: 1:CAS:528:DC%2BD2MXjtlOqu74%3D, PID: 15590897
-
Hwang J, Kleinhenz DJ, Lassegue B, Griendling KK, Dikalov S, Hart CM. Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol. 2005;288:C899–905.
-
(2005)
Am J Physiol Cell Physiol
, vol.288
, pp. C899-C905
-
-
Hwang, J.1
Kleinhenz, D.J.2
Lassegue, B.3
Griendling, K.K.4
Dikalov, S.5
Hart, C.M.6
-
93
-
-
79961075382
-
Anti-inflammatory and antioxidant properties of a new arylidene-thiazolidinedione in macrophages
-
COI: 1:CAS:528:DC%2BC3MXhtVOksLvE, PID: 21728966
-
Faine LA, Rudnicki M, Cesar FA, et al. Anti-inflammatory and antioxidant properties of a new arylidene-thiazolidinedione in macrophages. Curr Med Chem. 2011;18:3351–60.
-
(2011)
Curr Med Chem
, vol.18
, pp. 3351-3360
-
-
Faine, L.A.1
Rudnicki, M.2
Cesar, F.A.3
-
94
-
-
28044456326
-
Impact of thiazolidinedione therapy on atherogenesis
-
PID: 16105480
-
van Wijk JP, Rabelink TJ. Impact of thiazolidinedione therapy on atherogenesis. Curr Atheroscler Rep. 2005;7:369–74.
-
(2005)
Curr Atheroscler Rep
, vol.7
, pp. 369-374
-
-
van Wijk, J.P.1
Rabelink, T.J.2
-
95
-
-
0033582522
-
Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling
-
COI: 1:CAS:528:DyaK1MXhsFSlsLs%3D, PID: 9988743
-
Houston M, Estevez A, Chumley P, et al. Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. J Biol Chem. 1999;274:4985–94.
-
(1999)
J Biol Chem
, vol.274
, pp. 4985-4994
-
-
Houston, M.1
Estevez, A.2
Chumley, P.3
-
96
-
-
84863479133
-
Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis
-
COI: 1:CAS:528:DC%2BC38XhtlOgtLfN, PID: 22099531
-
Higgins P, Dawson J, Lees KR, McArthur K, Quinn TJ, Walters MR. Xanthine oxidase inhibition for the treatment of cardiovascular disease: a systematic review and meta-analysis. Cardiovasc Ther. 2012;30:217–26.
-
(2012)
Cardiovasc Ther
, vol.30
, pp. 217-226
-
-
Higgins, P.1
Dawson, J.2
Lees, K.R.3
McArthur, K.4
Quinn, T.J.5
Walters, M.R.6
-
97
-
-
5344274543
-
Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk
-
COI: 1:CAS:528:DC%2BD2cXotFCmsbw%3D, PID: 15464681
-
Mercuro G, Vitale C, Cerquetani E, et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol. 2004;94:932–5.
-
(2004)
Am J Cardiol
, vol.94
, pp. 932-935
-
-
Mercuro, G.1
Vitale, C.2
Cerquetani, E.3
-
98
-
-
26044463720
-
Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease
-
COI: 1:CAS:528:DC%2BD2MXhtVymsrbL, PID: 16214034
-
Baldus S, Koster R, Chumley P, et al. Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease. Free Radic Biol Med. 2005;39:1184–90.
-
(2005)
Free Radic Biol Med
, vol.39
, pp. 1184-1190
-
-
Baldus, S.1
Koster, R.2
Chumley, P.3
-
99
-
-
78650827558
-
Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress
-
COI: 1:CAS:528:DC%2BC3MXkt1entw%3D%3D, PID: 21122851
-
Tousoulis D, Andreou I, Tsiatas M, et al. Effects of rosuvastatin and allopurinol on circulating endothelial progenitor cells in patients with congestive heart failure: the impact of inflammatory process and oxidative stress. Atherosclerosis. 2011;214:151–7.
-
(2011)
Atherosclerosis
, vol.214
, pp. 151-157
-
-
Tousoulis, D.1
Andreou, I.2
Tsiatas, M.3
-
100
-
-
80051675515
-
Tetrahydrobiopterin: biochemistry and pathophysiology
-
COI: 1:CAS:528:DC%2BC3MXhtFSmtbnF, PID: 21867484
-
Werner ER, Blau N, Thony B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J. 2011;438:397–414.
-
(2011)
Biochem J
, vol.438
, pp. 397-414
-
-
Werner, E.R.1
Blau, N.2
Thony, B.3
-
101
-
-
78649908061
-
Tetrahydrobiopterin: pleiotropic roles in cardiovascular pathophysiology
-
COI: 1:CAS:528:DC%2BC3MXps1Ol, PID: 20837663
-
Cunnington C, Channon KM. Tetrahydrobiopterin: pleiotropic roles in cardiovascular pathophysiology. Heart. 2010;96:1872–7.
-
(2010)
Heart
, vol.96
, pp. 1872-1877
-
-
Cunnington, C.1
Channon, K.M.2
-
102
-
-
0037305699
-
The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications
-
COI: 1:CAS:528:DC%2BD3sXpvVCqsg%3D%3D, PID: 12653200
-
Vasquez-Vivar J, Kalyanaraman B, Martasek P. The role of tetrahydrobiopterin in superoxide generation from eNOS: enzymology and physiological implications. Free Radic Res. 2003;37:121–7.
-
(2003)
Free Radic Res
, vol.37
, pp. 121-127
-
-
Vasquez-Vivar, J.1
Kalyanaraman, B.2
Martasek, P.3
-
103
-
-
84901638616
-
Tetrahydrobiopterin in cardiovascular health and disease
-
COI: 1:CAS:528:DC%2BC2cXos1ahsL8%3D, PID: 24294830
-
Bendall JK, Douglas G, McNeill E, Channon KM, Crabtree MJ. Tetrahydrobiopterin in cardiovascular health and disease. Antioxidants Redox Signaling. 2014;20:3040–77.
-
(2014)
Antioxidants Redox Signaling
, vol.20
, pp. 3040-3077
-
-
Bendall, J.K.1
Douglas, G.2
McNeill, E.3
Channon, K.M.4
Crabtree, M.J.5
-
104
-
-
0034739459
-
Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis
-
COI: 1:CAS:528:DC%2BD3cXptVSjtbc%3D, PID: 11056088
-
Tiefenbacher CP, Bleeke T, Vahl C, Amann K, Vogt A, Kubler W. Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation. 2000;102:2172–9.
-
(2000)
Circulation
, vol.102
, pp. 2172-2179
-
-
Tiefenbacher, C.P.1
Bleeke, T.2
Vahl, C.3
Amann, K.4
Vogt, A.5
Kubler, W.6
-
105
-
-
34247220499
-
Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice
-
COI: 1:CAS:528:DC%2BD2sXislCrs78%3D, PID: 17272747
-
Hattori Y, Hattori S, Wang X, Satoh H, Nakanishi N, Kasai K. Oral administration of tetrahydrobiopterin slows the progression of atherosclerosis in apolipoprotein E-knockout mice. Arterioscler Thromb Vasc Biol. 2007;27:865–70.
-
(2007)
Arterioscler Thromb Vasc Biol
, vol.27
, pp. 865-870
-
-
Hattori, Y.1
Hattori, S.2
Wang, X.3
Satoh, H.4
Nakanishi, N.5
Kasai, K.6
-
106
-
-
41149105370
-
Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia
-
COI: 1:CAS:528:DC%2BD1cXkvFWgsLY%3D, PID: 17916662
-
Cosentino F, Hurlimann D, Delli Gatti C, et al. Chronic treatment with tetrahydrobiopterin reverses endothelial dysfunction and oxidative stress in hypercholesterolaemia. Heart. 2008;94:487–92.
-
(2008)
Heart
, vol.94
, pp. 487-492
-
-
Cosentino, F.1
Hurlimann, D.2
Delli Gatti, C.3
-
107
-
-
48449093231
-
AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats
-
COI: 1:CAS:528:DC%2BD1cXpslWrsr4%3D, PID: 18539157
-
Wenzel P, Schulz E, Oelze M, et al. AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats. Free Radic Biol Med. 2008;45:619–26.
-
(2008)
Free Radic Biol Med
, vol.45
, pp. 619-626
-
-
Wenzel, P.1
Schulz, E.2
Oelze, M.3
-
108
-
-
82755198575
-
Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and/or prevention?
-
PID: 21860805
-
Pashkow FJ. Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and/or prevention? Int J Inflam. 2011;2011:514623.
-
(2011)
Int J Inflam
, vol.2011
, pp. 514623
-
-
Pashkow, F.J.1
-
109
-
-
0034283054
-
Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E)
-
COI: 1:CAS:528:DC%2BD3cXms1ynu70%3D, PID: 10969031
-
Carr AC, Zhu BZ, Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res. 2000;87:349–54.
-
(2000)
Circ Res
, vol.87
, pp. 349-354
-
-
Carr, A.C.1
Zhu, B.Z.2
Frei, B.3
-
110
-
-
12244289625
-
Vitamin C as an antioxidant: evaluation of its role in disease prevention
-
COI: 1:CAS:528:DC%2BD3sXhs12isL0%3D, PID: 12569111
-
Padayatty SJ, Katz A, Wang Y, et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr. 2003;22:18–35.
-
(2003)
J Am Coll Nutr
, vol.22
, pp. 18-35
-
-
Padayatty, S.J.1
Katz, A.2
Wang, Y.3
-
111
-
-
41149150716
-
NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities
-
COI: 1:CAS:528:DC%2BD1cXis1ajt7s%3D, PID: 18227481
-
Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care. 2008;31(2):S170–80.
-
(2008)
Diabetes Care
, vol.31
, Issue.2
, pp. S170-S180
-
-
Paravicini, T.M.1
Touyz, R.M.2
-
112
-
-
33947405296
-
Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients
-
COI: 1:CAS:528:DC%2BD2sXjsVGhurs%3D, PID: 17386345
-
Plantinga Y, Ghiadoni L, Magagna A, et al. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens. 2007;20:392–7.
-
(2007)
Am J Hypertens
, vol.20
, pp. 392-397
-
-
Plantinga, Y.1
Ghiadoni, L.2
Magagna, A.3
-
113
-
-
0242409623
-
Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers
-
COI: 1:CAS:528:DC%2BD3sXovVenu78%3D, PID: 14612206
-
Tousoulis D, Antoniades C, Tentolouris C, et al. Effects of combined administration of vitamins C and E on reactive hyperemia and inflammatory process in chronic smokers. Atherosclerosis. 2003;170:261–7.
-
(2003)
Atherosclerosis
, vol.170
, pp. 261-267
-
-
Tousoulis, D.1
Antoniades, C.2
Tentolouris, C.3
-
114
-
-
0038489192
-
Effects of antioxidant vitamins C and E on endothelial function and thrombosis/fibrinolysis system in smokers
-
COI: 1:CAS:528:DC%2BD3sXlt1KqtL4%3D, PID: 12783111
-
Antoniades C, Tousoulis D, Tentolouris C, et al. Effects of antioxidant vitamins C and E on endothelial function and thrombosis/fibrinolysis system in smokers. Thromb Haemost. 2003;89:990–5.
-
(2003)
Thromb Haemost
, vol.89
, pp. 990-995
-
-
Antoniades, C.1
Tousoulis, D.2
Tentolouris, C.3
-
115
-
-
0029925181
-
Randomised controlled trial of vitamin E in patients with coronary disease: cambridge heart antioxidant study (CHAOS)
-
COI: 1:CAS:528:DyaK28XisFyhur4%3D, PID: 8622332
-
Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: cambridge heart antioxidant study (CHAOS). Lancet. 1996;347:781–6.
-
(1996)
Lancet
, vol.347
, pp. 781-786
-
-
Stephens, N.G.1
Parsons, A.2
Schofield, P.M.3
Kelly, F.4
Cheeseman, K.5
Mitchinson, M.J.6
-
116
-
-
33750617640
-
Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials
-
COI: 1:CAS:528:DC%2BD28XhtFWgtrvI, PID: 17023716, quiz 954–5
-
Bleys J, Miller 3rd ER, Pastor-Barriuso R, Appel LJ, Guallar E. Vitamin-mineral supplementation and the progression of atherosclerosis: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2006;84:880–7. quiz 954–5.
-
(2006)
Am J Clin Nutr
, vol.84
, pp. 880-887
-
-
Bleys, J.1
Miller, E.R.2
Pastor-Barriuso, R.3
Appel, L.J.4
Guallar, E.5
-
117
-
-
56149111693
-
Vitamins E and C in the prevention of cardiovascular disease in men: the physicians’ health study II randomized controlled trial
-
COI: 1:CAS:528:DC%2BD1cXhtlOrtLvP, PID: 18997197
-
Sesso HD, Buring JE, Christen WG, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the physicians’ health study II randomized controlled trial. JAMA. 2008;300:2123–33.
-
(2008)
JAMA
, vol.300
, pp. 2123-2133
-
-
Sesso, H.D.1
Buring, J.E.2
Christen, W.G.3
-
118
-
-
34548040480
-
A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the women’s antioxidant cardiovascular study
-
COI: 1:CAS:528:DC%2BD2sXhtVSqtrvK, PID: 17698683
-
Cook NR, Albert CM, Gaziano JM, et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the women’s antioxidant cardiovascular study. Arch Intern Med. 2007;167:1610–8.
-
(2007)
Arch Intern Med
, vol.167
, pp. 1610-1618
-
-
Cook, N.R.1
Albert, C.M.2
Gaziano, J.M.3
-
119
-
-
33645796222
-
Homocysteine lowering and cardiovascular events after acute myocardial infarction
-
COI: 1:CAS:528:DC%2BD28XjsVKgtbw%3D, PID: 16531614
-
Bonaa KH, Njolstad I, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354:1578–88.
-
(2006)
N Engl J Med
, vol.354
, pp. 1578-1588
-
-
Bonaa, K.H.1
Njolstad, I.2
Ueland, P.M.3
-
120
-
-
20444428707
-
Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, vitamins B6 and B12
-
COI: 1:CAS:528:DC%2BD2MXltFWjsL0%3D, PID: 15939064
-
Till U, Rohl P, Jentsch A, et al. Decrease of carotid intima-media thickness in patients at risk to cerebral ischemia after supplementation with folic acid, vitamins B6 and B12. Atherosclerosis. 2005;181:131–5.
-
(2005)
Atherosclerosis
, vol.181
, pp. 131-135
-
-
Till, U.1
Rohl, P.2
Jentsch, A.3
-
121
-
-
58149163618
-
Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials
-
COI: 1:CAS:528:DC%2BD1MXhvV2iu78%3D, PID: 19029125
-
Antoniades C, Antonopoulos AS, Tousoulis D, Marinou K, Stefanadis C. Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials. Eur Heart J. 2009;30:6–15.
-
(2009)
Eur Heart J
, vol.30
, pp. 6-15
-
-
Antoniades, C.1
Antonopoulos, A.S.2
Tousoulis, D.3
Marinou, K.4
Stefanadis, C.5
-
122
-
-
33748645122
-
5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling
-
COI: 1:CAS:528:DC%2BD28XptVOrsbY%3D, PID: 16940192
-
Antoniades C, Shirodaria C, Warrick N, et al. 5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling. Circulation. 2006;114:1193–201.
-
(2006)
Circulation
, vol.114
, pp. 1193-1201
-
-
Antoniades, C.1
Shirodaria, C.2
Warrick, N.3
-
123
-
-
1342309318
-
Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the vitamin intervention for stroke prevention (VISP) randomized controlled trial
-
COI: 1:CAS:528:DC%2BD2cXhtVylsL4%3D, PID: 14762035
-
Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA. 2004;291:565–75.
-
(2004)
JAMA
, vol.291
, pp. 565-575
-
-
Toole, J.F.1
Malinow, M.R.2
Chambless, L.E.3
-
124
-
-
53049110571
-
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial
-
Gissi HFI, Tavazzi L, Maggioni AP, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial. Lancet. 2008;372:1223–30.
-
(2008)
Lancet
, vol.372
, pp. 1223-1230
-
-
Gissi, H.F.I.1
Tavazzi, L.2
Maggioni, A.P.3
-
125
-
-
84862829128
-
Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials
-
COI: 1:CAS:528:DC%2BC38XhvVOrtb8%3D, PID: 22317966
-
Wang Q, Liang X, Wang L, et al. Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials. Atherosclerosis. 2012;221:536–43.
-
(2012)
Atherosclerosis
, vol.221
, pp. 536-543
-
-
Wang, Q.1
Liang, X.2
Wang, L.3
-
126
-
-
84878249491
-
The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: results of the GO-FISH trial
-
COI: 1:CAS:528:DC%2BC3sXpslylsbs%3D, PID: 23275364
-
Miller 3rd ER, Juraschek SP, Anderson CA, et al. The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: results of the GO-FISH trial. Diabetes Care. 2013;36:1462–9.
-
(2013)
Diabetes Care
, vol.36
, pp. 1462-1469
-
-
Miller, E.R.1
Juraschek, S.P.2
Anderson, C.A.3
-
127
-
-
84891596777
-
Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome
-
COI: 1:CAS:528:DC%2BC2cXksFCqtQ%3D%3D, PID: 24401211
-
Tousoulis D, Plastiras A, Siasos G, et al. Omega-3 PUFAs improved endothelial function and arterial stiffness with a parallel antiinflammatory effect in adults with metabolic syndrome. Atherosclerosis. 2014;232:10–6.
-
(2014)
Atherosclerosis
, vol.232
, pp. 10-16
-
-
Tousoulis, D.1
Plastiras, A.2
Siasos, G.3
-
128
-
-
84878016675
-
Effects of Omega-3 fatty acids on endothelial function, arterial wall properties, inflammatory and fibrinolytic status in smokers: a cross over study
-
PID: 22100606
-
Siasos G, Tousoulis D, Oikonomou E, et al. Effects of Omega-3 fatty acids on endothelial function, arterial wall properties, inflammatory and fibrinolytic status in smokers: a cross over study. Int J Cardiol. 2013;166:340–6.
-
(2013)
Int J Cardiol
, vol.166
, pp. 340-346
-
-
Siasos, G.1
Tousoulis, D.2
Oikonomou, E.3
-
129
-
-
1342332361
-
Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-beta to prevent human essential hypertension
-
COI: 1:CAS:528:DC%2BD2cXntlegsA%3D%3D, PID: 14749737
-
Das UN. Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-beta to prevent human essential hypertension. Eur J Clin Nutr. 2004;58:195–203.
-
(2004)
Eur J Clin Nutr
, vol.58
, pp. 195-203
-
-
Das, U.N.1
-
130
-
-
77956063072
-
Cardiovascular effects of marine omega-3 fatty acids
-
COI: 1:CAS:528:DC%2BC3cXhtVantr3M, PID: 20638121
-
Saravanan P, Davidson NC, Schmidt EB, Calder PC. Cardiovascular effects of marine omega-3 fatty acids. Lancet. 2010;376:540–50.
-
(2010)
Lancet
, vol.376
, pp. 540-550
-
-
Saravanan, P.1
Davidson, N.C.2
Schmidt, E.B.3
Calder, P.C.4
-
131
-
-
84903592141
-
Effect of dietary N - 3 polyunsaturated Fatty acids on oxidant/antioxidant status in macrosomic offspring of diabetic rats
-
COI: 1:STN:280:DC%2BC2cfoslGrsg%3D%3D
-
Guermouche B, Soulimane-Mokhtari NA, Bouanane S, Merzouk H, Merzouk S, Narce M. Effect of dietary N - 3 polyunsaturated Fatty acids on oxidant/antioxidant status in macrosomic offspring of diabetic rats. BioMed Res Intern. 2014;2014:368107.
-
(2014)
BioMed Res Intern
, vol.2014
, pp. 368107
-
-
Guermouche, B.1
Soulimane-Mokhtari, N.A.2
Bouanane, S.3
Merzouk, H.4
Merzouk, S.5
Narce, M.6
-
132
-
-
47249084623
-
Polyunsaturated fatty acids as antioxidants
-
COI: 1:CAS:528:DC%2BD1cXoslWmsb8%3D
-
Richard D, Kefi K, Barbe U, Bausero P, Visioli F. Polyunsaturated fatty acids as antioxidants. Pharmacol Res: Off J Ital Pharmacol Soc. 2008;57:451–5.
-
(2008)
Pharmacol Res: Off J Ital Pharmacol Soc
, vol.57
, pp. 451-455
-
-
Richard, D.1
Kefi, K.2
Barbe, U.3
Bausero, P.4
Visioli, F.5
-
133
-
-
84891295312
-
Effect of conjugated linoleic acid and omega-3 fatty acid supplementation on inflammatory and oxidative stress markers in atherosclerotic patients
-
PID: 24575132
-
Hassan Eftekhari M, Aliasghari F, Babaei-Beigi MA, Hasanzadeh J. Effect of conjugated linoleic acid and omega-3 fatty acid supplementation on inflammatory and oxidative stress markers in atherosclerotic patients. ARYA atherosclerosis. 2013;9:311–8.
-
(2013)
ARYA atherosclerosis
, vol.9
, pp. 311-318
-
-
Hassan Eftekhari, M.1
Aliasghari, F.2
Babaei-Beigi, M.A.3
Hasanzadeh, J.4
-
134
-
-
84876803871
-
The role of long chain omega-3 polyunsaturated fatty acids in reducing lipid peroxidation among elderly patients with mild cognitive impairment: a case–control study
-
COI: 1:CAS:528:DC%2BC38XhtF2rt7fK, PID: 22898566
-
Lee LK, Shahar S, Rajab N, Yusoff NA, Jamal RA, Then SM. The role of long chain omega-3 polyunsaturated fatty acids in reducing lipid peroxidation among elderly patients with mild cognitive impairment: a case–control study. J Nutr Biochem. 2013;24:803–8.
-
(2013)
J Nutr Biochem
, vol.24
, pp. 803-808
-
-
Lee, L.K.1
Shahar, S.2
Rajab, N.3
Yusoff, N.A.4
Jamal, R.A.5
Then, S.M.6
-
135
-
-
0037426745
-
Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men
-
PID: 12519921
-
Mukamal KJ, Conigrave KM, Mittleman MA, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med. 2003;348:109–18.
-
(2003)
N Engl J Med
, vol.348
, pp. 109-118
-
-
Mukamal, K.J.1
Conigrave, K.M.2
Mittleman, M.A.3
-
136
-
-
84891921502
-
Tea and non-tea flavonol intakes in relation to atherosclerotic vascular disease mortality in older women
-
COI: 1:CAS:528:DC%2BC3sXhslKnsrfO
-
Ivey KL, Lewis JR, Prince RL, Hodgson JM. Tea and non-tea flavonol intakes in relation to atherosclerotic vascular disease mortality in older women. Br J Nut. 2013;110:1648–55.
-
(2013)
Br J Nut
, vol.110
, pp. 1648-1655
-
-
Ivey, K.L.1
Lewis, J.R.2
Prince, R.L.3
Hodgson, J.M.4
-
137
-
-
77953474824
-
Plant polyphenols as dietary antioxidants in human health and disease
-
PID: 20716914
-
Pandey KB, Rizvi SI. Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev. 2009;2:270–8.
-
(2009)
Oxid Med Cell Longev
, vol.2
, pp. 270-278
-
-
Pandey, K.B.1
Rizvi, S.I.2
-
138
-
-
0035171808
-
DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging activity of flavonoids obtained from some medicinal plants
-
COI: 1:CAS:528:DC%2BD3MXnt12jurk%3D, PID: 11642334
-
Okawa M, Kinjo J, Nohara T, Ono M. DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging activity of flavonoids obtained from some medicinal plants. Biol Pharm Bull. 2001;24:1202–5.
-
(2001)
Biol Pharm Bull
, vol.24
, pp. 1202-1205
-
-
Okawa, M.1
Kinjo, J.2
Nohara, T.3
Ono, M.4
-
139
-
-
0033976054
-
Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-alpha secretion, and NF-kappaB-dependent gene expression in RAW 264.7 macrophages
-
COI: 1:CAS:528:DC%2BD3cXjtV2qsg%3D%3D, PID: 10631311
-
Park YC, Rimbach G, Saliou C, Valacchi G, Packer L. Activity of monomeric, dimeric, and trimeric flavonoids on NO production, TNF-alpha secretion, and NF-kappaB-dependent gene expression in RAW 264.7 macrophages. FEBS Lett. 2000;465:93–7.
-
(2000)
FEBS Lett
, vol.465
, pp. 93-97
-
-
Park, Y.C.1
Rimbach, G.2
Saliou, C.3
Valacchi, G.4
Packer, L.5
-
140
-
-
1342268337
-
Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells
-
COI: 1:CAS:528:DC%2BD2cXlvFOrtQ%3D%3D, PID: 14630700
-
Mackenzie GG, Carrasquedo F, Delfino JM, Keen CL, Fraga CG, Oteiza PI. Epicatechin, catechin, and dimeric procyanidins inhibit PMA-induced NF-kappaB activation at multiple steps in Jurkat T cells. FASEB J. 2004;18:167–9.
-
(2004)
FASEB J
, vol.18
, pp. 167-169
-
-
Mackenzie, G.G.1
Carrasquedo, F.2
Delfino, J.M.3
Keen, C.L.4
Fraga, C.G.5
Oteiza, P.I.6
-
141
-
-
77953050012
-
Physiological concentrations of dietary polyphenols regulate vascular endothelial cell expression of genes important in cardiovascular health
-
COI: 1:CAS:528:DC%2BC3cXmtFWqs7s%3D, PID: 20021702
-
Nicholson SK, Tucker GA, Brameld JM. Physiological concentrations of dietary polyphenols regulate vascular endothelial cell expression of genes important in cardiovascular health. Br J Nutr. 2010;103:1398–403.
-
(2010)
Br J Nutr
, vol.103
, pp. 1398-1403
-
-
Nicholson, S.K.1
Tucker, G.A.2
Brameld, J.M.3
-
142
-
-
77957833229
-
The regular consumption of a polyphenol-rich apple does not influence endothelial function: a randomized double-blind trial in hypercholesterolemic adults
-
COI: 1:CAS:528:DC%2BC3cXht1Cgt7%2FJ, PID: 20683465
-
Auclair S, Chironi G, Milenkovic D, et al. The regular consumption of a polyphenol-rich apple does not influence endothelial function: a randomized double-blind trial in hypercholesterolemic adults. Eur J Clin Nutr. 2010;64:1158–65.
-
(2010)
Eur J Clin Nutr
, vol.64
, pp. 1158-1165
-
-
Auclair, S.1
Chironi, G.2
Milenkovic, D.3
-
143
-
-
84858326289
-
Recent applications of grape polyphenols in foods, beverages and supplements
-
COI: 1:CAS:528:DC%2BC3cXhsVGms7bF, PID: 20653555
-
Gollucke AP. Recent applications of grape polyphenols in foods, beverages and supplements. Recent Pat Food Nutr Agric. 2010;2:105–9.
-
(2010)
Recent Pat Food Nutr Agric
, vol.2
, pp. 105-109
-
-
Gollucke, A.P.1
-
144
-
-
46649098436
-
Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials
-
COI: 1:CAS:528:DC%2BD1cXoslylsL4%3D, PID: 18614722
-
Hooper L, Kroon PA, Rimm EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88:38–50.
-
(2008)
Am J Clin Nutr
, vol.88
, pp. 38-50
-
-
Hooper, L.1
Kroon, P.A.2
Rimm, E.B.3
-
145
-
-
84870054444
-
Molecular mechanisms of the cardiovascular protective effects of polyphenols
-
COI: 1:CAS:528:DC%2BC38Xhs12ls7%2FM, PID: 22935143
-
Andriantsitohaina R, Auger C, Chataigneau T, et al. Molecular mechanisms of the cardiovascular protective effects of polyphenols. Br J Nutr. 2012;108:1532–49.
-
(2012)
Br J Nutr
, vol.108
, pp. 1532-1549
-
-
Andriantsitohaina, R.1
Auger, C.2
Chataigneau, T.3
-
146
-
-
84864616510
-
The protective effects of green tea polyphenols: lipid profile, inflammation, and antioxidant capacity in rats fed an atherogenic diet and dextran sodium sulfate
-
COI: 1:CAS:528:DC%2BC38XhtFCrsL%2FE, PID: 22846079
-
Bornhoeft J, Castaneda D, Nemoseck T, Wang P, Henning SM, Hong MY. The protective effects of green tea polyphenols: lipid profile, inflammation, and antioxidant capacity in rats fed an atherogenic diet and dextran sodium sulfate. J Med Food. 2012;15:726–32.
-
(2012)
J Med Food
, vol.15
, pp. 726-732
-
-
Bornhoeft, J.1
Castaneda, D.2
Nemoseck, T.3
Wang, P.4
Henning, S.M.5
Hong, M.Y.6
-
147
-
-
79952355001
-
Tea consumption enhances endothelial-dependent vasodilation; a meta-analysis
-
COI: 1:CAS:528:DC%2BC3MXjtl2msbc%3D, PID: 21394199
-
Ras RT, Zock PL, Draijer R. Tea consumption enhances endothelial-dependent vasodilation; a meta-analysis. PLoS One. 2011;6:e16974.
-
(2011)
PLoS One
, vol.6
, pp. e16974
-
-
Ras, R.T.1
Zock, P.L.2
Draijer, R.3
-
148
-
-
0029035495
-
Endothelium-dependent vasorelaxation caused by various plant extracts
-
COI: 1:CAS:528:DyaK2MXms1WgtL4%3D, PID: 7564372
-
Fitzpatrick DF, Hirschfield SL, Ricci T, Jantzen P, Coffey RG. Endothelium-dependent vasorelaxation caused by various plant extracts. J Cardiovasc Pharmacol. 1995;26:90–5.
-
(1995)
J Cardiovasc Pharmacol
, vol.26
, pp. 90-95
-
-
Fitzpatrick, D.F.1
Hirschfield, S.L.2
Ricci, T.3
Jantzen, P.4
Coffey, R.G.5
-
149
-
-
48049106159
-
How do dietary flavanols improve vascular function? A position paper
-
COI: 1:CAS:528:DC%2BD1cXpsVGjs70%3D, PID: 18358827
-
Schewe T, Steffen Y, Sies H. How do dietary flavanols improve vascular function? A position paper. Arch Biochem Biophys. 2008;476:102–6.
-
(2008)
Arch Biochem Biophys
, vol.476
, pp. 102-106
-
-
Schewe, T.1
Steffen, Y.2
Sies, H.3
-
150
-
-
0035985099
-
Biological properties of olive oil phytochemicals
-
COI: 1:CAS:528:DC%2BD38XltFSmu7k%3D, PID: 12058980
-
Visioli F, Galli C. Biological properties of olive oil phytochemicals. Crit Rev Food Sci Nutr. 2002;42:209–21.
-
(2002)
Crit Rev Food Sci Nutr
, vol.42
, pp. 209-221
-
-
Visioli, F.1
Galli, C.2
-
151
-
-
85047699295
-
Effect of ingestion of virgin olive oil on human low-density lipoprotein composition
-
COI: 1:CAS:528:DC%2BD38XitVCrur8%3D, PID: 11857044
-
Gimeno E, Fito M, Lamuela-Raventos RM, et al. Effect of ingestion of virgin olive oil on human low-density lipoprotein composition. Eur J Clin Nutr. 2002;56:114–20.
-
(2002)
Eur J Clin Nutr
, vol.56
, pp. 114-120
-
-
Gimeno, E.1
Fito, M.2
Lamuela-Raventos, R.M.3
-
152
-
-
75549090263
-
Acute effects of different types of oil consumption on endothelial function, oxidative stress status and vascular inflammation in healthy volunteers
-
COI: 1:CAS:528:DC%2BD1MXhs1Smt7%2FJ
-
Tousoulis D, Papageorgiou N, Antoniades C, et al. Acute effects of different types of oil consumption on endothelial function, oxidative stress status and vascular inflammation in healthy volunteers. Br J Nut. 2010;103:43–9.
-
(2010)
Br J Nut
, vol.103
, pp. 43-49
-
-
Tousoulis, D.1
Papageorgiou, N.2
Antoniades, C.3
-
153
-
-
79953789494
-
Divergent anti-inflammatory effects of different oil acute consumption on healthy individuals
-
COI: 1:CAS:528:DC%2BC3MXkt1Wlt74%3D, PID: 21326271
-
Papageorgiou N, Tousoulis D, Psaltopoulou T, et al. Divergent anti-inflammatory effects of different oil acute consumption on healthy individuals. Eur J Clin Nutr. 2011;65:514–9.
-
(2011)
Eur J Clin Nutr
, vol.65
, pp. 514-519
-
-
Papageorgiou, N.1
Tousoulis, D.2
Psaltopoulou, T.3
-
154
-
-
27244432775
-
Adherence to the Mediterranean diet is associated with total antioxidant capacity in healthy adults: the ATTICA study
-
COI: 1:CAS:528:DC%2BD2MXhtVaksL3K, PID: 16155285
-
Pitsavos C, Panagiotakos DB, Tzima N, et al. Adherence to the Mediterranean diet is associated with total antioxidant capacity in healthy adults: the ATTICA study. Am J Clin Nutr. 2005;82:694–9.
-
(2005)
Am J Clin Nutr
, vol.82
, pp. 694-699
-
-
Pitsavos, C.1
Panagiotakos, D.B.2
Tzima, N.3
-
155
-
-
0028991128
-
Formation of F2-isoprostanes in oxidized low density lipoprotein: inhibitory effect of hydroxytyrosol
-
COI: 1:CAS:528:DyaK2MXntlShsrc%3D
-
Salami M, Galli C, De Angelis L, Visioli F. Formation of F2-isoprostanes in oxidized low density lipoprotein: inhibitory effect of hydroxytyrosol. Pharmacol Res: Off J Ital Pharmacol Soc. 1995;31:275–9.
-
(1995)
Pharmacol Res: Off J Ital Pharmacol Soc
, vol.31
, pp. 275-279
-
-
Salami, M.1
Galli, C.2
De Angelis, L.3
Visioli, F.4
-
156
-
-
84884680087
-
Polyphenols: benefits to the cardiovascular system in health and in aging
-
COI: 1:CAS:528:DC%2BC2cXislyhsbY%3D, PID: 24077237
-
Khurana S, Venkataraman K, Hollingsworth A, Piche M, Tai TC. Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients. 2013;5:3779–827.
-
(2013)
Nutrients
, vol.5
, pp. 3779-3827
-
-
Khurana, S.1
Venkataraman, K.2
Hollingsworth, A.3
Piche, M.4
Tai, T.C.5
-
157
-
-
1842425919
-
Extra virgin olive oil biophenols inhibit cell-mediated oxidation of LDL by increasing the mRNA transcription of glutathione-related enzymes
-
COI: 1:CAS:528:DC%2BD2cXjtFWmt7s%3D, PID: 15051826
-
Masella R, Vari R, D'Archivio M, et al. Extra virgin olive oil biophenols inhibit cell-mediated oxidation of LDL by increasing the mRNA transcription of glutathione-related enzymes. J Nutr. 2004;134:785–91.
-
(2004)
J Nutr
, vol.134
, pp. 785-791
-
-
Masella, R.1
Vari, R.2
D'Archivio, M.3
-
158
-
-
79955506452
-
The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established
-
COI: 1:CAS:528:DC%2BC3MXltlCqu7s%3D, PID: 21451125
-
Hollman PC, Cassidy A, Comte B, et al. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J Nutr. 2011;141:989S–1009S.
-
(2011)
J Nutr
, vol.141
, pp. 989S-1009S
-
-
Hollman, P.C.1
Cassidy, A.2
Comte, B.3
-
159
-
-
0024401216
-
Age-related changes in the lipid compositions of rat and human tissues
-
COI: 1:CAS:528:DyaL1MXkvFCns78%3D, PID: 2779364
-
Kalen A, Appelkvist EL, Dallner G. Age-related changes in the lipid compositions of rat and human tissues. Lipids. 1989;24:579–84.
-
(1989)
Lipids
, vol.24
, pp. 579-584
-
-
Kalen, A.1
Appelkvist, E.L.2
Dallner, G.3
-
160
-
-
34547647850
-
Improvement in intestinal coenzyme q10 absorption by food intake
-
COI: 1:CAS:528:DC%2BD2sXhtFSms7rN
-
Ochiai A, Itagaki S, Kurokawa T, Kobayashi M, Hirano T, Iseki K. Improvement in intestinal coenzyme q10 absorption by food intake. Yakugaku zasshi: J Pharm Soc Japan. 2007;127:1251–4.
-
(2007)
Yakugaku zasshi: J Pharm Soc Japan
, vol.127
, pp. 1251-1254
-
-
Ochiai, A.1
Itagaki, S.2
Kurokawa, T.3
Kobayashi, M.4
Hirano, T.5
Iseki, K.6
-
161
-
-
84887950110
-
Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial
-
PID: 24192015
-
Lee BJ, Tseng YF, Yen CH, Lin PT. Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial. Nutr J. 2013;12:142.
-
(2013)
Nutr J
, vol.12
, pp. 142
-
-
Lee, B.J.1
Tseng, Y.F.2
Yen, C.H.3
Lin, P.T.4
-
162
-
-
84858701156
-
Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials
-
COI: 1:CAS:528:DC%2BC38XktlGlsbs%3D, PID: 22088605
-
Gao L, Mao Q, Cao J, Wang Y, Zhou X, Fan L. Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials. Atherosclerosis. 2012;221:311–6.
-
(2012)
Atherosclerosis
, vol.221
, pp. 311-316
-
-
Gao, L.1
Mao, Q.2
Cao, J.3
Wang, Y.4
Zhou, X.5
Fan, L.6
-
163
-
-
77953099666
-
CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function
-
COI: 1:CAS:528:DC%2BC3cXlsFGrs70%3D, PID: 20361197
-
Tiyerili V, Zimmer S, Jung S, et al. CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function. Basic Res Cardiol. 2010;105:465–77.
-
(2010)
Basic Res Cardiol
, vol.105
, pp. 465-477
-
-
Tiyerili, V.1
Zimmer, S.2
Jung, S.3
-
164
-
-
42449136138
-
Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe study
-
PID: 18417461
-
Van Gaal LF, Scheen AJ, Rissanen AM, Rossner S, Hanotin C, Ziegler O. Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe study. Eur Heart J. 2008;29:1761–71.
-
(2008)
Eur Heart J
, vol.29
, pp. 1761-1771
-
-
Van Gaal, L.F.1
Scheen, A.J.2
Rissanen, A.M.3
Rossner, S.4
Hanotin, C.5
Ziegler, O.6
-
165
-
-
0027479814
-
Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase
-
PID: 8439298
-
O'Donnell BV, Tew DG, Jones OT, England PJ. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem J. 1993;290(1):41–9.
-
(1993)
Biochem J
, vol.290
, Issue.1
, pp. 41-49
-
-
O'Donnell, B.V.1
Tew, D.G.2
Jones, O.T.3
England, P.J.4
-
166
-
-
84883170266
-
Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis
-
PID: 23965970
-
Kinkade K, Streeter J, Miller FJ. Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. Int J Mol Sci. 2013;14:17017–28.
-
(2013)
Int J Mol Sci
, vol.14
, pp. 17017-17028
-
-
Kinkade, K.1
Streeter, J.2
Miller, F.J.3
-
167
-
-
84874525887
-
Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition
-
PID: 23239832
-
Liu Y, Davidson BP, Yue Q, et al. Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. Circ Cardiovasc Imaging. 2013;6:74–82.
-
(2013)
Circ Cardiovasc Imaging
, vol.6
, pp. 74-82
-
-
Liu, Y.1
Davidson, B.P.2
Yue, Q.3
-
168
-
-
84883286431
-
Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties
-
COI: 1:CAS:528:DC%2BC3sXht1OqsbbF, PID: 23908248
-
Khanicheh E, Qi Y, Xie A, et al. Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties. Arterioscler Thromb Vasc Biol. 2013;33:2187–92.
-
(2013)
Arterioscler Thromb Vasc Biol
, vol.33
, pp. 2187-2192
-
-
Khanicheh, E.1
Qi, Y.2
Xie, A.3
-
169
-
-
84866183230
-
Targeting NADPH oxidases in vascular pharmacology
-
COI: 1:CAS:528:DC%2BC38XkvFWqtr8%3D
-
Schramm A, Matusik P, Osmenda G, Guzik TJ. Targeting NADPH oxidases in vascular pharmacology. Vasc Pharmacol. 2012;56:216–31.
-
(2012)
Vasc Pharmacol
, vol.56
, pp. 216-231
-
-
Schramm, A.1
Matusik, P.2
Osmenda, G.3
Guzik, T.J.4
-
170
-
-
0035980160
-
Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(−) and systolic blood pressure in mice
-
COI: 1:CAS:528:DC%2BD3MXmvFSrt7k%3D, PID: 11532901
-
Rey FE, Cifuentes ME, Kiarash A, Quinn MT, Pagano PJ. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(−) and systolic blood pressure in mice. Circ Res. 2001;89:408–14.
-
(2001)
Circ Res
, vol.89
, pp. 408-414
-
-
Rey, F.E.1
Cifuentes, M.E.2
Kiarash, A.3
Quinn, M.T.4
Pagano, P.J.5
|